Caribou Biosciences Standard Deviation
| CRBU Stock | | | USD 1.95 0.02 1.04% |
The Standard Deviation is a measure of how spread out the prices or returns of an asset are on average. It is the most widely used risk indicator in the field of investing and finance. Standard Deviation is commonly used to measure confidence in statistical conclusions regarding certain equity instruments or portfolios of equities. Below is Caribou Biosciences's current Standard Deviation with peer comparisons and related risk metrics.
Current Standard Deviation Value
Caribou Biosciences has a Standard Deviation of 4.54, indicating elevated price variability. This places Caribou Biosciences toward the higher end of the volatility range for Stock.
Standard Deviation | = | SQRT(V) |
| = | 4.54 | |
Standard Deviation Peers Comparison
Relative to peers, Caribou Biosciences's Standard Deviation is below the group average of 5.91. Peer readings range from 3.07 (Enanta Pharmaceuticals) to 9.07 (Aardvark Therapeutics Common), reflecting wide dispersion across the sector. Caribou Biosciences has exhibited less price dispersion than the peer average over the measured period.
Standard Deviation Relative To Other Indicators
The chart below plots Standard Deviation against Maximum Drawdown for Caribou Biosciences and its peers. Each point represents one equity — position along the horizontal axis shows Standard Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Comparing Standard Deviation (
4.54 ) to Maximum Drawdown (
20.34 ) for Caribou Biosciences yields a
4.48 multiple. This indicates Maximum Drawdown is significantly higher than Standard Deviation for Caribou Biosciences.
Methodology, Assumptions & Data Sources
The current Standard Deviation for Caribou Biosciences is 4.54. Caribou Biosciences' Standard Deviation is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.
Other Technical Indicators